This necessitated extensive reverse engineering of B-ALL cell lines using clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 genome editing and incorporation of validated epitopes into the CD19 amino acid sequence. Here, CD19 is linked to acute lymphoblastic leukemia.